title: Targeting the Vascular Endothelial Growth Factor Pathway in Gastric Cancer: A Hit or a Miss?
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY ilsond@mskcc.org.
authors.forename: David H
authors.initials: DH
authors.lastname: Ilson
mesh_terms: D006801:Humans; D058990:Molecular Targeted Therapy; D011725:Pyridines / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000037:antagonists & inhibitors
chemical_list: D011725:Pyridines; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C553458:apatinib; C000588866:KDR protein, human; D040301:Vascular Endothelial Growth Factor Receptor-2